Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 5:00 pm Purchase | 2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,294 16.200% | 11,250 (+5.60%) | Filing History |
| 2024-10-17 5:00 pm Unchanged | 2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,642 16.000% | 0 (Unchanged) | Filing History |
| 2024-08-19 4:05 pm Purchase | 2024-08-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,642 18.800% | 16,667 (+8.64%) | Filing History |
| 2024-05-06 4:05 pm Sale | 2024-05-02 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 201,044 19.300% | -3,333 (-1.63%) | Filing History |
| 2024-03-19 4:10 pm Purchase | 2024-03-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 204,377 21.000% | 16,875 (+9.00%) | Filing History |
| 2024-03-15 12:15 pm Purchase | 2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 192,975 20.000% | 18,113 (+10.36%) | Filing History |
| 2024-03-15 12:13 pm Purchase | 2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 187,502 19.500% | 18,113 (+10.69%) | Filing History |
| 2024-03-06 5:05 pm Purchase | 2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 169,389 18.300% | 10,833 (+6.83%) | Filing History |
| 2024-03-06 5:03 pm Purchase | 2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 174,862 18.900% | 10,833 (+6.60%) | Filing History |
| 2024-02-07 5:29 pm Purchase | 2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | Gruber Michele | 45,625 5.500% | 1,458 (+3.30%) | Filing History |
| 2024-01-25 4:06 pm Unchanged | 2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | Leaf Huang | 69,445 9.600% | 0 (Unchanged) | Filing History |
| 2024-01-03 4:59 pm Purchase | 2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | SABBY MANAGEMENT LLC | 72,477 11.000% | 72,477 (New Position) | Filing History |
| 2023-06-21 5:07 pm Purchase | 2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 164,029 20.800% | 164,029 (New Position) | Filing History |
| 2023-06-21 5:05 pm Purchase | 2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 158,555 20.100% | 158,555 (New Position) | Filing History |
| 2023-03-29 3:02 pm Purchase | 2023-03-19 | 13G | Lipella Pharmaceuticals Inc. LIPO | Gruber Michele | 44,167 5.800% | 44,167 (New Position) | Filing History |
| 2023-02-09 3:31 pm Purchase | 2022-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | Leaf Huang | 69,445 9.700% | 69,445 (New Position) | Filing History |
| 2022-12-29 5:20 pm Purchase | 2022-12-19 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 144,451 18.600% | 144,451 (New Position) | Filing History |
| 2022-12-29 5:18 pm Purchase | 2022-12-19 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 149,925 19.300% | 149,925 (New Position) | Filing History |